 FemTech: empowering reproductive rights or FEM-TRAP for surveillance?Dylan Hofmann Medical Law Review, 2024, vol. 32, issue 4, 468-485 Abstract: The emergence of FemTech technologies promises to revolutionize women’s health and reproductive rights but conceals an insidious trap of surveillance and control in the hands of private and state actors. This article examines the extent to which FemTech technologies, under the guise of empowerment, enable private actors to play a leading role in managing reproductive rights, replacing largely inactive States in this crucial function. The analysis shows how private FemTech companies are becoming critical players in implementing and defending these rights, often in response to the inaction or inadequacies of States. The article approaches the FemTech phenomenon from several angles, including the promises of empowerment, concerns about surveillance and control, and the ambivalent roles of private actors as implementers and defenders of reproductive rights. This structure makes it possible to offer a critical analysis of the legal, societal, and ethical implications of FemTech, highlighting the tensions between the promises of empowerment and the risks of surveillance and control. Keywords: abortion; FemTech; fertility treatment; privacy; private actors; reproductive rights (search for similar items in EconPapers) Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:oup:medlaw:v:32:y:2024:i:4:p:468-485. Access Statistics for this article Medical Law Review is currently edited by Professor Sara Fovargue and Professor Jose Miola More articles in Medical Law Review from Oxford University Press |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.